142 related articles for article (PubMed ID: 38698172)
61. Clinical significance of preoperative serum sialic acid levels in colorectal cancer: utility in the detection of patients at high risk of tumor recurrence.
Feijoo-Carnero C; Rodríguez-Berrocal FJ; Páez de la Cadena M; Ayude D; de Carlos A; Martínez-Zorzano VS
Int J Biol Markers; 2004; 19(1):38-45. PubMed ID: 15077925
[TBL] [Abstract][Full Text] [Related]
62. Persistent high postoperative carcinoembryonic antigen in colorectal cancer patients--is it important?
Filiz AI; Sucullu I; Kurt Y; Karakas DO; Gulec B; Akin ML
Clinics (Sao Paulo); 2009; 64(4):287-94. PubMed ID: 19488584
[TBL] [Abstract][Full Text] [Related]
63. Serum miR-200c is a novel prognostic and metastasis-predictive biomarker in patients with colorectal cancer.
Toiyama Y; Hur K; Tanaka K; Inoue Y; Kusunoki M; Boland CR; Goel A
Ann Surg; 2014 Apr; 259(4):735-43. PubMed ID: 23982750
[TBL] [Abstract][Full Text] [Related]
64. Carbohydrate antigen 19-9 is a valuable prognostic factor in colorectal cancer patients with normal levels of carcinoembryonic antigen and may help predict lung metastasis.
Lin PC; Lin JK; Lin CC; Wang HS; Yang SH; Jiang JK; Lan YT; Lin TC; Li AF; Chen WS; Chang SC
Int J Colorectal Dis; 2012 Oct; 27(10):1333-8. PubMed ID: 22426691
[TBL] [Abstract][Full Text] [Related]
65. CEA to peritoneal carcinomatosis index (PCI) ratio is prognostic in patients with colorectal cancer peritoneal carcinomatosis undergoing cytoreduction surgery and intraperitoneal chemotherapy: A retrospective cohort study.
Kozman MA; Fisher OM; Rebolledo BJ; Parikh R; Valle SJ; Arrowaili A; Alzahrani N; Liauw W; Morris DL
J Surg Oncol; 2018 Mar; 117(4):725-736. PubMed ID: 29266235
[TBL] [Abstract][Full Text] [Related]
66. The role of carcinoembryonic antigen as an assessment tool for predicting disease severity among patients with colorectal cancer in resource-poor setting of Kwazulu-Natal, South Africa.
Naicker YD; Moolla Z; Madiba T
Pan Afr Med J; 2021; 39():185. PubMed ID: 34584610
[TBL] [Abstract][Full Text] [Related]
67. Trajectories of Perioperative Serum Tumor Markers and Colorectal Cancer Outcomes: A Retrospective, Multicenter Longitudinal Cohort Study.
Li C; Zhang D; Pang X; Pu H; Lei M; Fan B; Lv J; You D; Li Z; Zhang T
EBioMedicine; 2021 Dec; 74():103706. PubMed ID: 34801967
[TBL] [Abstract][Full Text] [Related]
68. Apolipoprotein A-I levels in the survival of patients with colorectal cancer: a retrospective study.
Xie H; Wei L; Wang Q; Tang S; Gan J
Front Endocrinol (Lausanne); 2024; 15():1318416. PubMed ID: 38919478
[TBL] [Abstract][Full Text] [Related]
69. Prognostic Value of Lymphovascular Invasion in Patients with Stage III Colorectal Cancer: A Retrospective Study.
Zhong JW; Yang SX; Chen RP; Zhou YH; Ye MS; Miao L; Xue ZX; Lu GR
Med Sci Monit; 2019 Aug; 25():6043-6050. PubMed ID: 31408453
[TBL] [Abstract][Full Text] [Related]
70. Prognostic value of serum neutrophil gelatinase-associated lipocalin in metastatic and nonmetastatic colorectal cancer.
Martí J; Fuster J; Solà AM; Hotter G; Molina R; Pelegrina A; Ferrer J; Deulofeu R; Fondevila C; García-Valdecasas JC
World J Surg; 2013 May; 37(5):1103-9. PubMed ID: 23389669
[TBL] [Abstract][Full Text] [Related]
71. Development and validation of prognostic nomograms based on De Ritis ratio and clinicopathological features for patients with stage II/III colorectal cancer.
Fu J; Du F; Tian T; Huang H; Zhang L; Li D; Liu Y; Zhang D; Gao L; Zheng T; Liu Y; Zhao Y
BMC Cancer; 2023 Jul; 23(1):620. PubMed ID: 37400788
[TBL] [Abstract][Full Text] [Related]
72. The utility and prognostic value of CA 19-9 and CEA serum markers in the long-term follow up of patients with colorectal cancer. A single-center experience over 13 years.
Tumay V; Guner OS
Ann Ital Chir; 2020; 91():494-503. PubMed ID: 32990277
[TBL] [Abstract][Full Text] [Related]
73. Prognostic significance of pre- and postoperative serum carcinoembryonic antigen levels in patients with colorectal cancer.
Wang JY; Lu CY; Chu KS; Ma CJ; Wu DC; Tsai HL; Yu FJ; Hsieh JS
Eur Surg Res; 2007; 39(4):245-50. PubMed ID: 17457032
[TBL] [Abstract][Full Text] [Related]
74. Development and validation of nomograms for predicting survival in patients with non-metastatic colorectal cancer.
Jiang H; Tang E; Xu D; Chen Y; Zhang Y; Tang M; Xiao Y; Zhang Z; Deng X; Li H; Lin M
Oncotarget; 2017 May; 8(18):29857-29864. PubMed ID: 28415740
[TBL] [Abstract][Full Text] [Related]
75. A prognostic model for colorectal cancer based on CEA and a 48-multiplex serum biomarker panel.
Björkman K; Jalkanen S; Salmi M; Mustonen H; Kaprio T; Kekki H; Pettersson K; Böckelman C; Haglund C
Sci Rep; 2021 Feb; 11(1):4287. PubMed ID: 33619304
[TBL] [Abstract][Full Text] [Related]
76. An elevated preoperative serum carbohydrate antigen 19-9 level is a significant predictor for peritoneal dissemination and poor survival in colorectal cancer.
Takakura Y; Ikeda S; Imaoka Y; Urushihara T; Itamoto T
Colorectal Dis; 2015 May; 17(5):417-25. PubMed ID: 25512077
[TBL] [Abstract][Full Text] [Related]
77. CA125: A superior prognostic biomarker for colorectal cancer compared to CEA, CA19-9 or CA242.
Björkman K; Mustonen H; Kaprio T; Kekki H; Pettersson K; Haglund C; Böckelman C
Tumour Biol; 2021; 43(1):57-70. PubMed ID: 33935125
[TBL] [Abstract][Full Text] [Related]
78. Comparative analysis of predictive biomarkers for therapeutical strategies in colorectal cancer.
Gasser M; Gerstlauer C; Grimm M; Bueter M; Lebedeva T; Lutz J; Maeder U; Ribas C; Ribas C; Nichiporuk E; Thalheimer A; Heemann U; Thiede A; Meyer D; Waaga-Gasser AM
Ann Surg Oncol; 2007 Apr; 14(4):1272-84. PubMed ID: 17211733
[TBL] [Abstract][Full Text] [Related]
79. Postoperative CEA is a better prognostic marker than CA19-9, hCGβ or TATI after resection of colorectal liver metastases.
Peltonen R; Österlund P; Lempinen M; Nordin A; Stenman UH; Isoniemi H
Tumour Biol; 2018 Jan; 40(1):1010428317752944. PubMed ID: 29378497
[TBL] [Abstract][Full Text] [Related]
80. Clinicopathologic features and oncologic outcomes of colorectal cancer patients with extremely high carcinoembryonic antigen.
Lee SY; Jo JS; Kim HJ; Kim CH; Ju JK; Kim YJ; Kim HR
Int J Colorectal Dis; 2015 Jan; 30(1):63-9. PubMed ID: 25367182
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
